Full text
PDF

Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aquilonius S. M., Eckernas S. A. Choline therapy in Huntington chorea. Neurology. 1977 Sep;27(9):887–889. doi: 10.1212/wnl.27.9.887. [DOI] [PubMed] [Google Scholar]
- Aquilonius S. M., Eckernås S. A., Sundwall A. Regional distribution of choline acetyltransferase in the human brain: changes in Huntington's chorea. J Neurol Neurosurg Psychiatry. 1975 Jul;38(7):669–677. doi: 10.1136/jnnp.38.7.669. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bird E. D., Iversen L. L. Huntington's chorea. Post-mortem measurement of glutamic acid decarboxylase, choline acetyltransferase and dopamine in basal ganglia. Brain. 1974 Sep;97(3):457–472. doi: 10.1093/brain/97.1.457. [DOI] [PubMed] [Google Scholar]
- Kanazawa I., Bird E., O'Connell R., Powell D. Evidence for a decrease in substance P content of substantia nigra in Huntington's chorea. Brain Res. 1977 Jan 21;120(2):387–392. doi: 10.1016/0006-8993(77)90919-2. [DOI] [PubMed] [Google Scholar]
- Klawans H. L., Jr, Rubovits R. Central cholinergic-anticholinergic antagonism in Huntington's chorea. Neurology. 1972 Feb;22(2):107–116. doi: 10.1212/wnl.22.2.107. [DOI] [PubMed] [Google Scholar]
- Leander S., Arner A., Johansson B. Effects of 4-aminopyridine on mechanical activity and noradrenaline release in the rat portal vein in vitro. Eur J Pharmacol. 1977 Dec 15;46(4):351–361. doi: 10.1016/0014-2999(77)90229-1. [DOI] [PubMed] [Google Scholar]
- Lundh H. Effects of 4-aminopyridine on neuromuscular transmission. Brain Res. 1978 Sep 22;153(2):307–318. doi: 10.1016/0006-8993(78)90409-2. [DOI] [PubMed] [Google Scholar]
- Lundh H., Leander S., Thesleff S. Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine. J Neurol Sci. 1977 May;32(1):29–43. doi: 10.1016/0022-510x(77)90037-5. [DOI] [PubMed] [Google Scholar]
- Lundh H., Nilsson O., Rosén I. 4-aminopyridine--a new drug tested in the treatment of Eaton-Lambert syndrome. J Neurol Neurosurg Psychiatry. 1977 Nov;40(11):1109–1112. doi: 10.1136/jnnp.40.11.1109. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Lundh H., Nilsson O., Rosén I. Effects of 4-aminopyridine in myasthenia gravis. J Neurol Neurosurg Psychiatry. 1979 Feb;42(2):171–175. doi: 10.1136/jnnp.42.2.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Marsden C. D. Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia? J Neurol Neurosurg Psychiatry. 1976 Dec;39(12):1204–1209. doi: 10.1136/jnnp.39.12.1204. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Murray N. M., Newsom-Davis J. Treatment with oral 4-aminopyridine in disorders of neuromuscular transmission. Neurology. 1981 Mar;31(3):265–271. doi: 10.1212/wnl.31.3.265. [DOI] [PubMed] [Google Scholar]
- Perry T. L., Wright J. M., Hansen S., MacLeod P. M. Isoniazid therapy of Huntington disease. Neurology. 1979 Mar;29(3):370–375. doi: 10.1212/wnl.29.3.370. [DOI] [PubMed] [Google Scholar]
- Schauf C. L., Colton C. A., Colton J. S., Davis F. A. Aminopyridines and sparteine as inhibitors of membrane potassium conductance: effects on Myxicola giant axons and the lobster neuromuscular junction. J Pharmacol Exp Ther. 1976 May;197(2):414–425. [PubMed] [Google Scholar]
- Shoulson I., Kartzinel R., Chase T. N. Huntington's disease: treatment with dipropylacetic acid and gamma-aminobutyric acid. Neurology. 1976 Jan;26(1):61–63. doi: 10.1212/wnl.26.1.61. [DOI] [PubMed] [Google Scholar]
- Terry R. D. Senile dementia. Fed Proc. 1978 Dec;37(14):2837–2840. [PubMed] [Google Scholar]
- Vizi E. S., van Dijk J., Foldes F. F. The effect of 4-aminopyridine on acetylcholine release. J Neural Transm. 1977;41(4):265–274. doi: 10.1007/BF01252021. [DOI] [PubMed] [Google Scholar]